Los Angeles Capital Management LLC Aclaris Therapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

  • $24.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023
BUY
$7.89 - $10.64 $591,797 - $798,063
75,006 New
75,006 $777,000
Q1 2019

Apr 25, 2019
SELL
$5.63 - $7.84 $63,140 - $87,925
-11,215 Closed
0 $0
Q4 2018

Feb 11, 2019
SELL
$6.3 - $15.4 $787 - $1,925
-125 Reduced 1.1%
11,215 $83,000
Q2 2018

Jul 31, 2018
BUY
$16.46 - $20.33 $186,656 - $230,542
11,340 New
11,340 $226,000

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $193M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email